AU2002348393A1 - Tyrosine kinase inhibitors - Google Patents

Tyrosine kinase inhibitors

Info

Publication number: AU2002348393A1
Authority: AU; Australia
Prior art keywords: tyrosine kinase; kinase inhibitors; inhibitors; tyrosine; kinase
Prior art date: 2001-10-25
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.): Abandoned

Application number

AU2002348393A

Other languages

English (en)

Inventor

Ian M. Bell

B. Wesley Trotter

C. Blair Zartman

Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)

Merck and Co Inc

Original Assignee

Merck and Co Inc

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2001-10-25

Filing date

2002-10-21

Publication date

2003-05-06

2002-10-21 Application filed by Merck and Co Inc filed Critical Merck and Co Inc

2003-05-06 Publication of AU2002348393A1 publication Critical patent/AU2002348393A1/en

Status Abandoned legal-status Critical Current

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D207/30—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
- C07D207/34—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms

Landscapes

Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

AU2002348393A 2001-10-25 2002-10-21 Tyrosine kinase inhibitors Abandoned AU2002348393A1 (en)

Applications Claiming Priority (3)

Application Number	Priority Date	Filing Date	Title
US34290201P	2001-10-25	2001-10-25
US60/342,902		2001-10-25
PCT/US2002/033919 WO2003035614A2 (fr)	2001-10-25	2002-10-21	Inhibiteurs de la tyrosine kinase

Publications (1)

Publication Number	Publication Date
AU2002348393A1 true AU2002348393A1 (en)	2003-05-06

Family

ID=23343779

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
AU2002348393A Abandoned AU2002348393A1 (en)	2001-10-25	2002-10-21	Tyrosine kinase inhibitors

Country Status (2)

Country	Link
AU (1)	AU2002348393A1 (fr)
WO (1)	WO2003035614A2 (fr)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
CN1829507A (zh) *	2003-07-24	2006-09-06	麦克公司	酪氨酸激酶抑制剂
EP2372363A1 (fr)	2005-09-20	2011-10-05	OSI Pharmaceuticals, Inc.	Marqueurs biologiques prédictifs d'une réaction anticancéreuse aux inhibiteurs kinase du récepteur du facteur de croissance 1 analogue à l'insuline
EP2400985A2 (fr)	2009-02-25	2012-01-04	OSI Pharmaceuticals, LLC	Thérapie anti-cancer combinée
JP2012519170A (ja)	2009-02-26	2012-08-23	オーエスアイ・ファーマシューティカルズ，エルエルシー	生体内の腫瘍細胞のｅｍｔステータスをモニターするためのｉｎｓｉｔｕ法
JP2012519281A (ja)	2009-02-27	2012-08-23	オーエスアイ・ファーマシューティカルズ，エルエルシー	間葉様腫瘍細胞またはその生成を阻害する薬剤を同定するための方法
WO2010099138A2 (fr)	2009-02-27	2010-09-02	Osi Pharmaceuticals, Inc.	Procédés pour l'identification d'agents qui inhibent les cellules tumorales de type mésenchymateuses ou leur formation
WO2010099364A2 (fr)	2009-02-27	2010-09-02	Osi Pharmaceuticals, Inc.	Méthodes d'identification d'agents qui inhibent les cellules cancéreuses mésenchymateuses ou leur formation
US20100316639A1 (en)	2009-06-16	2010-12-16	Genentech, Inc.	Biomarkers for igf-1r inhibitor therapy
AU2011223643A1 (en)	2010-03-03	2012-06-28	OSI Pharmaceuticals, LLC	Biological markers predictive of anti-cancer response to insulin-like growth factor-1 receptor kinase inhibitors
JP2013520998A (ja)	2010-03-03	2013-06-10	オーエスアイ・ファーマシューティカルズ，エルエルシー	インスリン様増殖因子−１受容体キナーゼ阻害剤に対する抗癌反応の予測に役立つ生物学的マーカー
WO2011112666A1 (fr)	2010-03-09	2011-09-15	OSI Pharmaceuticals, LLC	Thérapie anticancéreuse combinatoire
US20120214830A1 (en)	2011-02-22	2012-08-23	OSI Pharmaceuticals, LLC	Biological markers predictive of anti-cancer response to insulin-like growth factor-1 receptor kinase inhibitors in hepatocellular carcinoma
EP2702173A1 (fr)	2011-04-25	2014-03-05	OSI Pharmaceuticals, LLC	Utilisation de signatures de gènes de tem dans la découverte de médicaments contre le cancer, diagnostics et traitement du cancer
WO2013152252A1 (fr)	2012-04-06	2013-10-10	OSI Pharmaceuticals, LLC	Polythérapie antinéoplasique
JP6255038B2 (ja)	2013-02-26	2017-12-27	トリアクトセラピューティクス，インク．	癌治療
US9381246B2 (en)	2013-09-09	2016-07-05	Triact Therapeutics, Inc.	Cancer therapy

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
EP1139754A4 (fr) *	1998-12-31	2002-12-18	Sugen Inc	Composes 3-heteroarylidenyl-2-indolinone utilises pour modulation de l'activite de la proteine kinase et dans la chimiotherapie du cancer

2002
- 2002-10-21 AU AU2002348393A patent/AU2002348393A1/en not_active Abandoned
- 2002-10-21 WO PCT/US2002/033919 patent/WO2003035614A2/fr not_active Ceased

Also Published As

Publication number	Publication date
WO2003035614A3 (fr)	2004-03-18
WO2003035614A2 (fr)	2003-05-01

Publication	Publication Date	Title
AU2002361577A1 (en)	2003-05-12	Tyrosine kinase inhibitors
AU2002334355A1 (en)	2003-03-18	Protein tyrosine kinase inhibitors
AU2003299651A1 (en)	2004-06-30	Tyrosine kinase inhibitors
PL373300A1 (en)	2005-08-22	Novel tyrosine kinase inhibitors
AU2003298942A1 (en)	2004-06-30	Tyrosine kinase inhibitors
AU2001237041A1 (en)	2001-11-08	Kinase inhibitors
AU2003282891A1 (en)	2004-04-23	Novel tyrosine kinases inhibitors
AU2000240570A1 (en)	2001-10-08	Pyrrolopyrimidines as tyrosine kinase inhibitors
AU2002305260A1 (en)	2002-11-11	Pyrazole derived kinase inhibitors
AU2002348394A1 (en)	2003-05-06	Tyrosine kinase inhibitors
AU2437900A (en)	2000-08-07	Piperidinylquinolines as protein tyrosine kinase inhibitors
AU2003275282A1 (en)	2004-04-23	Novel tyrosine kinase inhibitors
AU2002357193A1 (en)	2003-07-09	Thienopyrimidine compounds as protein tyrosine kinase inhibitors
AU2002348020A1 (en)	2003-05-06	Tyrosine kinase inhibitors
AU2002348393A1 (en)	2003-05-06	Tyrosine kinase inhibitors
AU2002323406A1 (en)	2003-03-18	Tyrosine kinase inhibitors
AU2001241917A1 (en)	2001-09-12	Myt1 kinase inhibitors
AU2002327534A1 (en)	2003-03-03	Tyrosine kinase inhibitors
AU2002253350A1 (en)	2002-11-11	4-aminosulfonylquinazolines and -quinolines as tyrosine kinase inhibitors
AU2002304001A1 (en)	2003-01-02	Tyrosine kinase inhibitors
AU2002326758A1 (en)	2003-03-03	Tyrosine kinase inhibitors
AU2002326466A1 (en)	2003-02-17	Tyrosine kinase inhibitors
AU2002337972A1 (en)	2003-05-06	Tyrosine kinase inhibitors
AU2002355733A1 (en)	2003-02-17	Tyrosine kinase inhibitors
AU2002326760A1 (en)	2003-03-18	Tyrosine kinase inhibitors

Legal Events

Date	Code	Title	Description
2004-07-15	MK6	Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase